Integrated Analysis of Immune Infiltration and Hub Pyroptosis-Related Genes for Multiple Sclerosis

References

• Ashraf H, Solla P, Sechi LA. Current advancement of immunomodulatory drugs as potential pharmacotherapies for autoimmunity based neurological diseases. Pharmaceuticals. 2022;15:1077. doi:10.3390/ph15091077
   Web of Science ®Google Scholar
• Shinoda K, Li R, Rezk A, et al. Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. Proc Natl Acad Sci U S A. 2023;120:e2207291120. doi:10.1073/pnas.2207291120
   PubMed Web of Science ®Google Scholar
• Wiendl H, Schmierer K, Hodgkinson S, et al. Specific patterns of immune cell dynamics may explain the early onset and prolonged efficacy of cladribine tablets: a MAGNIFY-MS substudy. Neurol Neuroimmunol Neuroinflamm. 2023;10:e200048. doi:10.1212/NXI.0000000000200048
   PubMed Web of Science ®Google Scholar
• Gan J, Huang M, Lan G, et al. High glucose induces the loss of retinal pericytes partly via NLRP3-Caspase-1-GSDMD-mediated pyroptosis. Biomed Res Int. 2020;2020:4510628. doi:10.1155/2020/4510628
   PubMed Web of Science ®Google Scholar
• Zhang D, Li Y, Du C, et al. Evidence of pyroptosis and ferroptosis extensively involved in autoimmune diseases at the single-cell transcriptome level. J Transl Med. 2022;20:363. doi:10.1186/s12967-022-03566-6
   PubMed Web of Science ®Google Scholar
• Xu D, Ji Z, Qiang L. Molecular characteristics, clinical implication, and cancer immunity interactions of pyroptosis-related genes in breast cancer. Front Med. 2021;8:702638. doi:10.3389/fmed.2021.702638
   Web of Science ®Google Scholar
• Taabazuing CY, Okondo MC, Bachovchin DA. Pyroptosis and apoptosis pathways engage in bidirectional crosstalk in monocytes and macrophages. Cell Chem Biol. 2017;24:507–514.e504. doi:10.1016/j.chembiol.2017.03.009
   PubMed Web of Science ®Google Scholar
• Shi J, Gao W, Shao F. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci. 2017;42:245–254. doi:10.1016/j.tibs.2016.10.004
   PubMed Web of Science ®Google Scholar
• Sborgi L, Rühl S, Mulvihill E, et al. GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death. EMBO j. 2016;35:1766–1778. doi:10.15252/embj.201694696
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen X, Gueydan C, et al. Plasma membrane changes during programmed cell deaths. Cell Res. 2018;28:9–21. doi:10.1038/cr.2017.133
   PubMed Web of Science ®Google Scholar
• McKenzie BA, Dixit VM, Power C. Fiery cell death: pyroptosis in the central nervous system. Trends Neurosci. 2020;43:55–73. doi:10.1016/j.tins.2019.11.005
   PubMed Web of Science ®Google Scholar
• Barclay W, Shinohara ML. Inflammasome activation in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Brain Pathol. 2017;27:213–219. doi:10.1111/bpa.12477
   PubMed Web of Science ®Google Scholar
• McKenzie BA, Mamik MK, Saito LB, et al. Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis. Proc Natl Acad Sci U S A. 2018;115:E6065–e6074. doi:10.1073/pnas.1722041115
   PubMed Web of Science ®Google Scholar
• Liu ZK, Wu KF, Zhang RY, et al. Pyroptosis-Related LncRNA signature predicts prognosis and is associated with immune infiltration in hepatocellular carcinoma. Front Oncol. 2022;12:794034. doi:10.3389/fonc.2022.794034
   PubMed Web of Science ®Google Scholar
• Goris A, Vandebergh M, McCauley JL, et al. Genetics of multiple sclerosis: lessons from polygenicity. Lancet Neurol. 2022;21:830–842. doi:10.1016/S1474-4422(22)00255-1
   PubMed Web of Science ®Google Scholar
• Nussbaum YI, Manjunath Y, Suvilesh KN, et al. Current and prospective methods for assessing anti-tumor immunity in colorectal cancer. Int J Mol Sci. 2021;22:4802. doi:10.3390/ijms22094802
   PubMed Web of Science ®Google Scholar
• Nie H, Yan C, Zhou W, et al. Analysis of immune and inflammation characteristics of atherosclerosis from different sample sources. Oxid Med Cell Longev. 2022;2022:5491038. doi:10.1155/2022/5491038
   PubMed Web of Science ®Google Scholar
• Qiu K, Zeng T, Liao Y, et al. Identification of inflammation-related biomarker Pro-ADM for male patients with gout by comprehensive analysis. Front Immunol. 2021;12:798719. doi:10.3389/fimmu.2021.798719
   PubMed Web of Science ®Google Scholar
• Yao XQ, Chen JY, Yu ZH, et al. Bioinformatics analysis identified apolipoprotein E as a hub gene regulating neuroinflammation in macrophages and microglia following spinal cord injury. Front Immunol. 2022;13:964138. doi:10.3389/fimmu.2022.964138
   PubMed Web of Science ®Google Scholar
• Lu Y, Li K, Hu Y, et al. Expression of immune related genes and possible regulatory mechanisms in alzheimer’s disease. Front Immunol. 2021;12:768966. doi:10.3389/fimmu.2021.768966
   PubMed Web of Science ®Google Scholar
• Enz LS, Zeis T, Schmid D, et al. Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15. Neurol Neuroimmunol Neuroinflamm. 2020;7:e656. doi:10.1212/NXI.0000000000000656
   PubMed Web of Science ®Google Scholar
• Magliozzi R, Howell OW, Durrenberger P, et al. Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis. J Neuroinflammation. 2019;16:259. doi:10.1186/s12974-019-1650-x
   PubMed Web of Science ®Google Scholar
• Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453–457. doi:10.1038/nmeth.3337
   PubMed Web of Science ®Google Scholar
• Liberzon A, Birger C, Thorvaldsdóttir H, et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417–425. doi:10.1016/j.cels.2015.12.004
   PubMed Web of Science ®Google Scholar
• Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:7. doi:10.1186/1471-2105-14-7
   PubMed Web of Science ®Google Scholar
• Ye Y, Dai Q, Qi H. A novel defined pyroptosis-related gene signature for predicting the prognosis of ovarian cancer. Cell Death Discov. 2021;7:71. doi:10.1038/s41420-021-00451-x
   PubMed Web of Science ®Google Scholar
• Karki R, Kanneganti TD. Diverging inflammasome signals in tumorigenesis and potential targeting. Nat Rev Cancer. 2019;19:197–214. doi:10.1038/s41568-019-0123-y
   PubMed Web of Science ®Google Scholar
• Tang Y, Liang M, Tao L, et al. Machine learning-based diagnostic evaluation of shear-wave elastography in BI-RADS category 4 breast cancer screening: a multicenter, retrospective study. Quant Imaging Med Surg. 2022;12:1223–1234. doi:10.21037/qims-21-341
   PubMed Web of Science ®Google Scholar
• Xie R, Liu L, Lu X, et al. Identification of the diagnostic genes and immune cell infiltration characteristics of gastric cancer using bioinformatics analysis and machine learning. Front Genet. 2022;13:1067524. doi:10.3389/fgene.2022.1067524
   PubMedGoogle Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545–15550. doi:10.1073/pnas.0506580102
   PubMed Web of Science ®Google Scholar
• Sticht C, De La Torre C, Parveen A, et al. miRWalk: an online resource for prediction of microRNA binding sites. PLoS One. 2018;13:e0206239. doi:10.1371/journal.pone.0206239
   PubMed Web of Science ®Google Scholar
• Yeh IJ, Liu KT, Shen JH, et al. Identification of the potential prognostic markers from the miRNA-lncRNA-mRNA interactions for metastatic renal cancer via next-generation sequencing and bioinformatics. Diagnostics. 2020;10:228. doi:10.3390/diagnostics10040228
   Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–2504. doi:10.1101/gr.1239303
   PubMed Web of Science ®Google Scholar
• Grajchen E, Hendriks JJA, Bogie JFJ. The physiology of foamy phagocytes in multiple sclerosis. Acta Neuropathol Commun. 2018;6:124. doi:10.1186/s40478-018-0628-8
   PubMed Web of Science ®Google Scholar
• Bar-Or A, Li R. Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances. Lancet Neurol. 2021;20:470–483. doi:10.1016/S1474-4422(21)00063-6
   PubMed Web of Science ®Google Scholar
• Piacente F, Bottero M, Benzi A, et al. Neuroprotective potential of dendritic cells and sirtuins in multiple sclerosis. Int J Mol Sci. 2022;23:4352. doi:10.3390/ijms23084352
   PubMed Web of Science ®Google Scholar
• Jensen IJ, Jensen SN, Sjaastad FV, et al. Sepsis impedes EAE disease development and diminishes autoantigen-specific naive CD4 T cells. Elife. 2020;9. doi:10.7554/eLife.55800
   Web of Science ®Google Scholar
• Xie K, Chen YQ, Chai YS, et al. HMGB1 suppress the expression of IL-35 by regulating Naïve CD4+ T cell differentiation and aggravating Caspase-11-dependent pyroptosis in acute lung injury. Int Immunopharmacol. 2021;91:107295. doi:10.1016/j.intimp.2020.107295
   PubMed Web of Science ®Google Scholar
• Hamann I, Unterwalder N, Cardona AE, et al. Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells. Immunology. 2011;133:62–73. doi:10.1111/j.1365-2567.2011.03409.x
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang Y, Xia S, et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature. 2020;579:415–420. doi:10.1038/s41586-020-2071-9
   PubMed Web of Science ®Google Scholar
• Pinke KH, Zorzella-Pezavento SFG, Lara VS, et al. Should mast cells be considered therapeutic targets in multiple sclerosis? Neural Regen Res. 2020;15:1995–2007. doi:10.4103/1673-5374.282238
   PubMed Web of Science ®Google Scholar
• Ribatti D, Tamma R, Annese T. Mast cells and angiogenesis in multiple sclerosis. Inflamm Res. 2020;69:1103–1110. doi:10.1007/s00011-020-01394-2
   PubMed Web of Science ®Google Scholar
• Bonnekoh H, Scheffel J, Kambe N, et al. The role of mast cells in autoinflammation. Immunol Rev. 2018;282:265–275. doi:10.1111/imr.12633
   PubMed Web of Science ®Google Scholar
• De Bondt M, Hellings N, Opdenakker G, et al. Neutrophils: underestimated players in the pathogenesis of multiple sclerosis (MS). Int J Mol Sci. 2020;21:4558. doi:10.3390/ijms21124558
   PubMed Web of Science ®Google Scholar
• de Bont CM, Boelens WC, Pruijn GJM. NETosis, complement, and coagulation: a triangular relationship. Cell Mol Immunol. 2019;16:19–27. doi:10.1038/s41423-018-0024-0
   PubMed Web of Science ®Google Scholar
• Dubyak GR, Miller BA, Pearlman E. Pyroptosis in neutrophils: multimodal integration of inflammasome and regulated cell death signaling pathways. Immunol Rev. 2023;314:229–249. doi:10.1111/imr.13186
   PubMed Web of Science ®Google Scholar
• Wen R, Liu YP, Tong XX, et al. Molecular mechanisms and functions of pyroptosis in sepsis and sepsis-associated organ dysfunction. Front Cell Infect Microbiol. 2022;12:962139. doi:10.3389/fcimb.2022.962139
   PubMed Web of Science ®Google Scholar
• Kunzelmann K. Ion channels in regulated cell death. Cell Mol Life Sci. 2016;73:2387–2403. doi:10.1007/s00018-016-2208-z
   PubMed Web of Science ®Google Scholar
• Zheng T, Zhao C, Zhao B, et al. Impairment of the autophagy-lysosomal pathway and activation of pyroptosis in macular corneal dystrophy. Cell Death Discov. 2020;6:85. doi:10.1038/s41420-020-00320-z
   PubMed Web of Science ®Google Scholar
• Shi Y, Yang Y, Xu W, et al. E3 ubiquitin ligase SYVN1 is a key positive regulator for GSDMD-mediated pyroptosis. Cell Death Dis. 2022;13:106. doi:10.1038/s41419-022-04553-x
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu W, Zhong Y, et al. Metformin corrects glucose metabolism reprogramming and NLRP3 inflammasome-induced pyroptosis via inhibiting the TLR4/NF-κB/PFKFB3 signaling in trophoblasts: implication for a potential therapy of preeclampsia. Oxid Med Cell Longev. 2021;2021:1806344. doi:10.1155/2021/1806344
   PubMed Web of Science ®Google Scholar
• Downs KP, Nguyen H, Dorfleutner A, et al. An overview of the non-canonical inflammasome. Mol Aspects Med. 2020;76:100924. doi:10.1016/j.mam.2020.100924
   PubMed Web of Science ®Google Scholar
• Tian W, Wang Z, Tang NN, et al. Ascorbic acid sensitizes colorectal carcinoma to the cytotoxicity of arsenic trioxide via promoting reactive oxygen species-dependent apoptosis and pyroptosis. Front Pharmacol. 2020;11:123. doi:10.3389/fphar.2020.00123
   PubMed Web of Science ®Google Scholar
• Huang J, Chen P, Xiang Y, et al. Gut microbiota dysbiosis-derived macrophage pyroptosis causes polycystic ovary syndrome via steroidogenesis disturbance and apoptosis of granulosa cells. Int Immunopharmacol. 2022;107:108717. doi:10.1016/j.intimp.2022.108717
   PubMed Web of Science ®Google Scholar
• Freeman L, Guo H, David CN, et al. NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes. J Exp Med. 2017;214:1351–1370. doi:10.1084/jem.20150237
   PubMed Web of Science ®Google Scholar
• Shao S, Chen C, Shi G, et al. Therapeutic potential of the target on NLRP3 inflammasome in multiple sclerosis. Pharmacol Ther. 2021;227:107880. doi:10.1016/j.pharmthera.2021.107880
   PubMed Web of Science ®Google Scholar
• Pastar I, Sawaya AP, Marjanovic J, et al. Intracellular Staphylococcus aureus triggers pyroptosis and contributes to inhibition of healing due to perforin-2 suppression. J Clin Invest. 2021;131. doi:10.1172/JCI133727
   PubMed Web of Science ®Google Scholar
• Sun J, Li Y. Pyroptosis and respiratory diseases: a review of current knowledge. Front Immunol. 2022;13:920464. doi:10.3389/fimmu.2022.920464
   PubMed Web of Science ®Google Scholar
• Weigt SS, Palchevskiy V, Belperio JA. Inflammasomes and IL-1 biology in the pathogenesis of allograft dysfunction. J Clin Invest. 2017;127:2022–2029. doi:10.1172/JCI93537
   PubMed Web of Science ®Google Scholar
• Guo Q, Wu Y, Hou Y, et al. Cytokine secretion and pyroptosis of thyroid follicular cells mediated by enhanced NLRP3, NLRP1, NLRC4, and AIM2 Inflammasomes are associated with autoimmune thyroiditis. Front Immunol. 2018;9:1197. doi:10.3389/fimmu.2018.01197
   PubMed Web of Science ®Google Scholar
• Karimi E, Azari H, Tahmasebi A, et al. LncRNA-miRNA network analysis across the Th17 cell line reveals biomarker potency of lncRNA NEAT1 and KCNQ1OT1 in multiple sclerosis. J Cell Mol Med. 2022;26:2351–2362. doi:10.1111/jcmm.17256
   PubMed Web of Science ®Google Scholar
• Dastmalchi R, Ghafouri-Fard S, Omrani MD, et al. Dysregulation of long non-coding RNA profile in peripheral blood of multiple sclerosis patients. Mult Scler Relat Disord. 2018;25:219–226. doi:10.1016/j.msard.2018.07.044
   PubMedGoogle Scholar
• Gharesouran J, Taheri M, Sayad A, et al. Integrative analysis of OIP5-AS1/HUR1 to discover new potential biomarkers and therapeutic targets in multiple sclerosis. J Cell Physiol. 2019;234:17351–17360. doi:10.1002/jcp.28355
   PubMed Web of Science ®Google Scholar
• Ding Y, Li T, Yan X, et al. Identification of hub lncRNA ceRNAs in multiple sclerosis based on ceRNA mechanisms. Mol Genet Genomics. 2021;296:423–435. doi:10.1007/s00438-020-01750-1
   PubMed Web of Science ®Google Scholar
• Gandhi R, Healy B, Gholipour T, et al. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. Ann Neurol. 2013;73:729–740. doi:10.1002/ana.23880
   PubMed Web of Science ®Google Scholar
• Piket E, Zheleznyakova GY, Kular L, et al. Small non-coding RNAs as important players, biomarkers and therapeutic targets in multiple sclerosis: a comprehensive overview. J Autoimmun. 2019;101:17–25. doi:10.1016/j.jaut.2019.04.002
   PubMed Web of Science ®Google Scholar
• Selmaj I, Cichalewska M, Namiecinska M, et al. Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis. Ann Neurol. 2017;81:703–717. doi:10.1002/ana.24931
   PubMed Web of Science ®Google Scholar